Teachers Advisors’s Seres Therapeutics MCRB Stock Holding History

Teachers Advisors’s Portfolio MCRB Stock Details MCRB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	$263K	Hold	1,916	–	–	﹤0.01%	2772
2018 Q4	$173K	Hold	1,916	–	–	﹤0.01%	2877
2018 Q3	$291K	Sell	1,916 -22	-1%	-$3.56K	﹤0.01%	2836
2018 Q2	$333K	Hold	1,938	–	–	﹤0.01%	2832
2018 Q1	$284K	Hold	1,938	–	–	﹤0.01%	2772
2017 Q4	$393K	Hold	1,938	–	–	﹤0.01%	2667
2017 Q3	$622K	Hold	1,938	–	–	﹤0.01%	2490
2017 Q2	$438K	Buy	1,938 +23	+1%	+$4.72K	﹤0.01%	2652
2017 Q1	$432K	Sell	1,915 -140	-7%	-$28.4K	﹤0.01%	2605
2016 Q4	$407K	Buy	2,055 +623	+44%	+$136K	﹤0.01%	2640
2016 Q3	$352K	Hold	1,432	–	–	﹤0.01%	2648
2016 Q2	$832K	Buy	1,432 +795	+125%	+$466K	﹤0.01%	2129
2016 Q1	$339K	Hold	637	–	–	﹤0.01%	2547
2015 Q4	$447K	Buy	637 +204	+47%	+$134K	﹤0.01%	2474
2015 Q3	$257K	Buy	+433	New	+$353K	﹤0.01%	2769

Other funds holding MCRB

Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

AIM

ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

NAMA

Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Teachers Advisors's MCRB Position: Q1 2019 in Review

Teachers Advisors held its Seres Therapeutics (MCRB) position steady in Q1 2019 at 1,916 shares worth $263K. The position accounts for ﹤0.01% of the portfolio, ranked #2772.

Teachers Advisors first reported a position in MCRB in Q3 2015 and has held it in 15 quarters since. The position peaked at $832K in Q2 2016. 82 funds tracked by Wall St. Rank hold MCRB as of Q1 2019.

Teachers Advisors held 1,916 shares of Seres Therapeutics worth $263K as of Q1 2019.
Teachers Advisors left its Seres Therapeutics share count unchanged in Q1 2019.
Seres Therapeutics made up ﹤0.01% of Teachers Advisors's portfolio in Q1 2019, its #2772 holding.
Teachers Advisors first reported a position in Seres Therapeutics in Q3 2015 and has held it in 15 quarters since.
Teachers Advisors's Seres Therapeutics position peaked at $832K in Q2 2016.
82 funds tracked by Wall St. Rank held Seres Therapeutics as of Q1 2019.

Based on Teachers Advisors's 13F filing for Q1 2019, filed 14 May 2019.